Startup based in the United States, most recent round Seed.
Capsigen is a startup based in the United States. Its most recent tracked round is Seed.
Capsigen develops customized adeno-associated virus (AAV) capsids using its proprietary Transcription-Dependent Directed Evolution (TRADE™) platform to enable efficient and targeted delivery of gene therapies for various diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.